NASDAQ:IDXX
Idexx Laboratories Stock News
$522.70
-4.22 (-0.80%)
At Close: Jun 13, 2025
The Catalyst ® Cortisol Test provides veterinarians with real-time critical insights when evaluating dogs for Addison's disease and Cushing's syndrome WESTBROOK, Maine , June 5, 2025 /PRNewswire/ --
5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil
09:11am, Thursday, 15'th May 2025
Five high-flying medical instrument stocks are: DXCM, IDXX, NPCE, CLPT, FMS.
IDEXX Laboratories: Growth Remains Despite Weak Clinical Visits
02:35pm, Wednesday, 14'th May 2025
IDEXX Laboratories, Inc. delivered strong Q1 FY25 results with 4.7% organic revenue and 7% adjusted EPS growth, despite weak US clinical visits. I see catalysts ahead: potential U.S. tax cuts, normali
Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?
10:41am, Wednesday, 14'th May 2025
Here is how Idexx Laboratories (IDXX) and AngioDynamics (ANGO) have performed compared to their sector so far this year.
IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day
02:30pm, Tuesday, 13'th May 2025
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Andrew Emerson, Executive Vice President and Chief Financ
Compared to Estimates, Idexx (IDXX) Q1 Earnings: A Look at Key Metrics
10:36am, Thursday, 01'st May 2025
Although the revenue and EPS for Idexx (IDXX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street es
IDEXX Laboratories, Inc. (IDXX) Q1 2025 Earnings Conference Call Transcript
10:35am, Thursday, 01'st May 2025
IDEXX Laboratories, Inc. (NASDAQ:IDXX ) Q1 2025 Earnings Conference Call May 1, 2025 8:30 AM ET Company Participants Andrew Emerson - EVP, CFO and Treasurer Jay Mazelsky - President and CEO Conference
Idexx Laboratories (IDXX) Beats Q1 Earnings Estimates
08:40am, Thursday, 01'st May 2025
Idexx Laboratories (IDXX) came out with quarterly earnings of $2.96 per share, beating the Zacks Consensus Estimate of $2.92 per share. This compares to earnings of $2.81 per share a year ago.
IDEXX Laboratories raises annual profit view on strong demand for its pet diagnostics
08:21am, Thursday, 01'st May 2025
Animal diagnostics maker IDEXX Laboratories on Thursday raised its annual profit forecast after it beat Wall Street estimates for quarterly profit, as it benefited from customer retention and increase
IDEXX Laboratories Announces First Quarter Results
06:30am, Thursday, 01'st May 2025
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced first quarter results. “IDEXX drove solid execution in the f
Watch These 3 MedTech Stocks This Earnings Season: Beat or Miss?
10:35am, Wednesday, 30'th Apr 2025
The first-quarter 2025 earnings season is underway, with a number of top MedTech companies already releasing their numbers. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
Why Idexx Laboratories (IDXX) is a Top Growth Stock for the Long-Term
10:50am, Tuesday, 29'th Apr 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Seeking Clues to Idexx (IDXX) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
10:21am, Tuesday, 29'th Apr 2025
Besides Wall Street's top -and-bottom-line estimates for Idexx (IDXX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quar
Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth
11:08am, Thursday, 24'th Apr 2025
Idexx (IDXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IDXX Gears Up for Q1 Earnings: What to Expect From the Stock?
09:35am, Monday, 21'st Apr 2025
IDEXX Laboratories' first-quarter 2025 performance is expected to have benefited from a strong execution against strategic priorities.